REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novartis (Singapore) Pte Ltd (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novartis (Singapore) Pte Ltd Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: manufacture of other biological products and preparations for human use (manuf medicinal & pharmaceutical prods); Secondary Business Activity: wholesale of medicinal and pharmaceutical products (western)

Headquarters
20 Pasir Panjang Road, #10-25/28 Mapletree Business City, Singapore
Singapore; Singapore; Postal Code: 117439

Contact Details: Purchase the Novartis (Singapore) Pte Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Novartis (Singapore) Pte Ltd report to view the information.
Outstanding Shares:
Purchase the Novartis (Singapore) Pte Ltd report to view the information.
Financial Auditors:
Purchase the Novartis (Singapore) Pte Ltd report to view the information.
Incorporation Date:
August 01, 1986
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novartis (Singapore) Pte Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
9.02%▲
Total operating revenue
9.02%▲
Net Profit (Loss) for the Period
-31.34%▼
Total assets
50.39%▲
Total equity
9.19%▲
Net Profit Margin
-0.91%▼
Return on Equity (ROE)
-4.97%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo